|
LDA NEWS & UPDATES
April 30, 2023
| |
On 4.4.23, Lyme Disease Association, Inc. (LDA) President, Pat Smith, was interviewed on NJ radio station 101.5 by Host David Matthau, about the multiple dangerous tick-borne diseases in the state. A summary article about the in-depth and informative interview of Ms. Smith was posted to the NJ 101.5 website on 4.12.23. Read more. | |
Lone star ticks, credit: Jim Occi, Ph.D., Rutgers, CVD, and LDA Medical & Professional Advisory Board member | |
|
The feature-length documentary about Lyme disease The Quiet Epidemic will show in Ridgefield, CT on May 8, 2023. Tickets are $10. The show starts at 7 PM; doors open at 6 PM.
Ridgefield Playhouse
80 East Ridge Road
Ridgefield, CT 06877
Organizer: Lyme Connection
The film follows a girl from Brooklyn and a Duke University
| |
|
scientist both diagnosed with a disease said not to exist by many mainstream medical societies: Chronic Lyme disease. It begins as a patient story and evolves into an investigation that uncovers a paper trail of suppressed scientific research revealing why ticks - and their diseases - have been allowed to spread quietly around the globe.
Includes interviews from Dr. Steven Phillips, Dr. Richard Horowitz, Dr. Ken Liegner and investigative reporter Mary Beth Pfieffer. Read more.
| |
|
Powassan Virus; Canad. Med Assn. J. 5-2-64 | |
|
Yale School of Public Health (Blair, J.) 4.11.23, published “Tick-borne Powassan virus is being transmitted in concentrated clusters in New England, Yale study says.” The article details a study that contributes a better understanding of the particulars relating to Powassan virus transmission and may be of aid to public health efforts to curb infections.
According to the article, the study (PNAS, Vogels, C.B.F., et al., 4.11.23) uncovered how the spread of the virus seems to be highly contained, indicating that it is sustained in disseminated local hotspots with quite restricted mixing amongst the sites.
The Yale article states, "Most people infected with Powassan do not experience symptoms, but for some, it can result in brain swelling and even death. There are currently no vaccines or treatments for Powassan virus infection. Prevention is primarily dependent on education and control." Read more.
| |
Ticks and Tick-borne Diseases (Occi, J., et al.) 5.23, published “Rickettsia and relapsing fever Borrelia in Alectorobius kelleyi (Ixodida: Argasidae) from peri domestic bats in the northeastern United States.” The objective was to evaluate the incidence of Rickettsia and Borrelia pathogens in the parasitizing synanthropic bat species in the highly urbanized northeastern region of the United States. Read more. | |
| |
|
|
PLOS Global Public Health (Hart, C., et al.) 6.27.22, published “Community engaged tick surveillance and tickMAP as a public health tool to track the emergence of ticks and tick-borne diseases in New York.” The article article details a program that was used to acquire ticks and related information throughout New York State.
Collected ticks were differentiated and tested for several tick-borne pathogens. Of the tick samples, only I. scapularis was found to be regularly infected with pathogens of human importance, such as B. burgdorferi, B. miyamotoi, A. phagocytophilum, B. microti, and Powassan virus. Read more.
| |
eBioMedicine (Chung, M., et al.) 3.21.23 published “Systematic comparisons between Lyme disease and post-treatment Lyme disease syndrome in the U.S. with administrative claims data.” The data-driven study analyzed a nationwide administrative dataset consisting of over 98 billion billing and 1.4 billion prescription archives from the years 2008 – 2016 to uncover characteristics of Post Treatment Lyme Disease Syndrome (PTLDS) that may be of diagnostic or etiologic importance. Read more. | |
| |
|
According to a Market Watch article published 4.11.23, Moderna Inc. announced it is developing its first bacterial vaccines to protect against Lyme disease. This news was announced at Moderna’s fourth Vaccine Day, where they provided clinical and program updates. | |
Moderna has two Lyme vaccine candidates, mRNA-1982 and mRNA-1975, in development to prevent disease. The candidates are being designed to create antibodies for Borrelia species most common in the US and Europe - mRNA-1982 for Borrelia burgdorferi in the US and mRNA-1975 for four “major” Borrelia species in Europe. Read more. | |
|
Outbreak News Today, 4.8.23, reports death from Severe Fever with Thrombocytopenia Syndrome (SFTS), which is caused by the SFTS virus (genus Phlebovirus, family Bunyaviridae). It is reported that this disease has a high fatality rate (6%–30% of patients die). Between 2013 and 2022, there have been a total of 1,697 SFTS patients in Korea with 317 deaths.
In 2018, Health Day Reporter Dennis Thompson published “New Disease-Bearing Tick Could Spread Through US.” The Asian longhorned tick is a highly invasive and adaptable tick originating in regions of China that are similar in climate to much of the US. Its first detection was from NJ in 2017. Since then, the tick has been detected in 18 US states. According to CDC, “As of August 26, 2022, longhorned ticks have been found in Arkansas, Connecticut, Delaware, Georgia, Kentucky, Maryland, Massachusetts, Missouri, New Jersey, New York, North Carolina, Ohio, Pennsylvania, Rhode Island, South Carolina, Tennessee, Virginia, and West Virginia.” This tick is linked to SFTS, which is emerging in China, South Korea, and Japan. Read more.
| |
Longhorned Ticks, credit: James Occi, PhD, LDA Scientific & Professional Advisory Board | | |
|
Clinical Infectious Diseases (Hunt, K.M., et al.) 10.31.22, published “Racial Differences in the Diagnosis of Lyme Disease in Children.” Researcher findings were that black children with Lyme disease were less likely to have a “bull’s eye” or erythema migrans (EM) rash diagnosed compared with children of other races. Black children were also more likely to have a swollen joint compared to children of other races. Read more. | | |
|
|
The Department of Defense Congressionally Directed Medical Research Program (CDMRP) wishes to notify the research community of recently released Fiscal Year 2023 (FY23) funding opportunities for the Department of Defense (DOD) programs managed by the office of Congressionally Directed Medical Research Programs (CDMRP).
The CDMRP-TBDRP states, “Particularly encouraged are applications focused on persistent Lyme disease, and other tick-borne disease and conditions endemic to the U.S.” Read more.
| | |
|
Journal of Microbiology and Biotechnology (Jensen, G.S., et al.) 3.2.23 published “Disruption of Established Bacterial and Fungal Biofilms by a Blend of Enzymes and Botanical Extracts.” In this study researchers evaluated the effects of a nutraceutical enzyme and a botanical blend (NEBB) on established biofilm from five microbial strains with known implications in chronic human illnesses. Read more. | | |
|
Journal of Integrative and Complementary Medicine (Li, X. et al.) published 2.1.23 “Ginseng and Ginseng Herbal Formulas for Symptomatic Management of Fatigue: A Systematic Review and Meta-Analysis.” The objective of this study was to evaluate the safety and efficacy of ginseng and herbal formulas of ginseng for fatigue from previous clinical trials. Authors conducted searches of various publishers and databases through July 6, 2022, and then combined data and performed subgroup analysis by fatigue type, assessment instrument, and ginseng type. Read more. | |
|
“Healing from Lyme Disease”
Virtual online educational and healing experience with 50+ speakers
Hosts: Thomas Moorcroft, DO & Darin Ingels, ND
May 9-16, 2023
- Attendees can view all of each day’s speakers for free
- Live Q & A and healing experiences each day
- Attendees can purchase entire summit afterward if they choose
Learn more about the free online event.
| |
|
Latest LDA Lyme Case & Incidence Maps are now available on the website
Free to Download
| |
|
The Lyme Disease Association Inc. (LDA) does not charge any membership fees. Most of our
materials are free to download and most of our videos are free on YouTube. Our nationwide
doctor referral system is free to access. Printed brochures can be ordered for the cost of S&H.
| |
888-366-6611 Toll Free Info Line
| | | | |
